FR2360314A2 - Nouveaux vaccins perfectionnes a base de fractions ribosomales - Google Patents

Nouveaux vaccins perfectionnes a base de fractions ribosomales

Info

Publication number
FR2360314A2
FR2360314A2 FR7624124A FR7624124A FR2360314A2 FR 2360314 A2 FR2360314 A2 FR 2360314A2 FR 7624124 A FR7624124 A FR 7624124A FR 7624124 A FR7624124 A FR 7624124A FR 2360314 A2 FR2360314 A2 FR 2360314A2
Authority
FR
France
Prior art keywords
vaccines based
new advanced
ribosomal
ribosomal fractions
fractions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7624124A
Other languages
English (en)
French (fr)
Other versions
FR2360314B2 (xx
Inventor
Lucien Dussourd D Hinterland
Gerard Normier
Anne-Marie Pinel
Jacques Durand
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre SA
Original Assignee
Pierre Fabre SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre SA filed Critical Pierre Fabre SA
Priority to FR7624124A priority Critical patent/FR2360314A2/fr
Priority to BE179522A priority patent/BE857014R/xx
Priority to GB31746/77A priority patent/GB1590144A/en
Priority to AU27538/77A priority patent/AU511331B2/en
Priority to CA284,028A priority patent/CA1087093A/en
Priority to JP9304877A priority patent/JPS5320418A/ja
Priority to ZA00774733A priority patent/ZA774733B/xx
Priority to DE2735411A priority patent/DE2735411C2/de
Priority to ES461415A priority patent/ES461415A2/es
Publication of FR2360314A2 publication Critical patent/FR2360314A2/fr
Application granted granted Critical
Publication of FR2360314B2 publication Critical patent/FR2360314B2/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0266—Klebsiella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
FR7624124A 1976-08-06 1976-08-06 Nouveaux vaccins perfectionnes a base de fractions ribosomales Granted FR2360314A2 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FR7624124A FR2360314A2 (fr) 1976-08-06 1976-08-06 Nouveaux vaccins perfectionnes a base de fractions ribosomales
BE179522A BE857014R (fr) 1976-08-06 1977-07-20 Preparation de vaccins a base d'acides nucleiques arn associes a des polysaccharides extraits de germes microbiens.
GB31746/77A GB1590144A (en) 1976-08-06 1977-07-28 Vaccines based on ribosome fractions
AU27538/77A AU511331B2 (en) 1976-08-06 1977-08-02 Vaccines containing both ribosome and saccharide microorganism cell fractions
CA284,028A CA1087093A (en) 1976-08-06 1977-08-04 Vaccines based on a ribosome fraction combined with a saccharide fraction from bacteria
JP9304877A JPS5320418A (en) 1976-08-06 1977-08-04 Vaccine not containing cell
ZA00774733A ZA774733B (en) 1976-08-06 1977-08-05 Vaccines
DE2735411A DE2735411C2 (de) 1976-08-06 1977-08-05 Verfahren zur Herstellung von acellulären Impfstoffen auf Ribonucleinsäurebasis
ES461415A ES461415A2 (es) 1976-08-06 1977-08-05 Procedimiento para la preparacion de vacunas acelulares.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7624124A FR2360314A2 (fr) 1976-08-06 1976-08-06 Nouveaux vaccins perfectionnes a base de fractions ribosomales

Publications (2)

Publication Number Publication Date
FR2360314A2 true FR2360314A2 (fr) 1978-03-03
FR2360314B2 FR2360314B2 (xx) 1980-04-25

Family

ID=9176646

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7624124A Granted FR2360314A2 (fr) 1976-08-06 1976-08-06 Nouveaux vaccins perfectionnes a base de fractions ribosomales

Country Status (9)

Country Link
JP (1) JPS5320418A (xx)
AU (1) AU511331B2 (xx)
BE (1) BE857014R (xx)
CA (1) CA1087093A (xx)
DE (1) DE2735411C2 (xx)
ES (1) ES461415A2 (xx)
FR (1) FR2360314A2 (xx)
GB (1) GB1590144A (xx)
ZA (1) ZA774733B (xx)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1980000412A1 (en) * 1978-08-24 1980-03-20 N Gilmour Pasteurellosis vaccines
EP0031285A2 (fr) * 1979-12-21 1981-07-01 Pierre Fabre S.A. Préparations immunostimulantes à base d'ARN ribosomaux de Klebsiella pneumoniae et procédé de préparation de ces ARN
FR2475900A1 (fr) * 1980-02-20 1981-08-21 Fabre Sa Pierre Complexe vaccinal contenant un antigene specifique et vaccin le contenant
EP0238407A1 (fr) * 1986-03-18 1987-09-23 Pierre Fabre Medicament Procédés industriels de fabrication de vaccins ribosomaux et vaccins ribosomaux obtenus

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55106066U (xx) * 1979-01-19 1980-07-24
JPS639754Y2 (xx) * 1979-01-25 1988-03-23
US4293545A (en) 1980-03-31 1981-10-06 Norden Laboratories, Inc. Modified Pasteurella multocida bacteria vaccines
US4388299A (en) 1980-03-31 1983-06-14 Norden Laboratories, Inc. Modified pasteurella bacteria and vaccines prepared therefrom
US4328210A (en) 1980-03-31 1982-05-04 Norden Laboratories, Inc. Modified Pasteurella bacteria and vaccines prepared therefrom
US4335106A (en) 1980-03-31 1982-06-15 Norden Laboratories Inc. Processes for the growth of a modified Pasteurella multocida bacteria and preparation of a vaccine therefrom
US4626430A (en) * 1981-04-17 1986-12-02 Norden Laboratories, Inc. Processes for growth of modified Pasteurella haemolytica bacteria and preparation of a vaccine therefrom
US4506017A (en) * 1981-04-17 1985-03-19 Norden Laboratories, Inc. Modified Pasteurella haemolytica bacteria
US4559306A (en) * 1981-04-17 1985-12-17 Norden Laboratories, Inc. Modified Pasteurella multocida bacteria
JPS58191628A (ja) * 1982-05-04 1983-11-08 Aisin Seiki Co Ltd 車輌ル−フパネル開閉装置
JPS626614A (ja) * 1985-07-03 1987-01-13 株式会社チノー 温室の天窓制御装置
JPS62104526A (ja) * 1985-10-30 1987-05-15 株式会社チノー 温室の制御装置
DE19703437A1 (de) * 1997-01-30 1998-08-06 Luitpold Pharma Gmbh Gemische äußerer Membranen und/oder Zellwände von Bakterien zur oralen Immunisierung gegen Schleimhautinfektionen
GB2370839A (en) * 2001-01-06 2002-07-10 Benedikt Timmerman Immunogenic complex useful for disease control

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51142528A (en) * 1975-05-19 1976-12-08 Fabre Sa Pierre Production of vaccine based on antigenic libosome fractionation

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1980000412A1 (en) * 1978-08-24 1980-03-20 N Gilmour Pasteurellosis vaccines
EP0031285A2 (fr) * 1979-12-21 1981-07-01 Pierre Fabre S.A. Préparations immunostimulantes à base d'ARN ribosomaux de Klebsiella pneumoniae et procédé de préparation de ces ARN
EP0031285A3 (en) * 1979-12-21 1981-07-15 Pierre Fabre S.A. Immuno-stimulating preparations based on ribosomal rna and process for the preparation of the rna
WO1984000688A1 (fr) * 1979-12-21 1984-03-01 D Hinterland Lucien Dussourd Preparations immunostimulantes a base d'arn ribosomaux et procede de preparation des arn
FR2475900A1 (fr) * 1980-02-20 1981-08-21 Fabre Sa Pierre Complexe vaccinal contenant un antigene specifique et vaccin le contenant
EP0035429A1 (fr) * 1980-02-20 1981-09-09 Pierre Fabre S.A. Complexe vaccinal contenant un antigène spécifique et vaccin le contenant
EP0238407A1 (fr) * 1986-03-18 1987-09-23 Pierre Fabre Medicament Procédés industriels de fabrication de vaccins ribosomaux et vaccins ribosomaux obtenus
FR2596064A1 (fr) * 1986-03-18 1987-09-25 Pf Medicament Procedes industriels de fabrication de vaccins ribosomaux et vaccins ribosomaux obtenus

Also Published As

Publication number Publication date
BE857014R (fr) 1978-01-20
AU2753877A (en) 1979-02-08
FR2360314B2 (xx) 1980-04-25
ZA774733B (en) 1978-07-26
JPS5320418A (en) 1978-02-24
CA1087093A (en) 1980-10-07
AU511331B2 (en) 1980-08-14
DE2735411C2 (de) 1982-07-29
DE2735411A1 (de) 1978-02-09
GB1590144A (en) 1981-05-28
ES461415A2 (es) 1978-07-16

Similar Documents

Publication Publication Date Title
FR2360314A2 (fr) Nouveaux vaccins perfectionnes a base de fractions ribosomales
Høsrmand et al. Juvenile periodontitis localization of bone loss in relation to age, sex, and teeth
DE69410254D1 (de) Behandlung von mycobakteriellen erkrankungen durch verabreichung von bakrerientötende, durchlässigkeitserhöhende proteinfragmente
DK233385D0 (da) Humant monoclonalt antistof, praeparat indeholdende antistoffer og cellelinie, der udskiller antistoffet
HUP0203198A2 (hu) Tramadolvegyület és görcsoldó hatóanyagot tartalmazó gyógyászati készítmény, eljárás az előállítására és alkalmazása
IL130931A0 (en) Small molecules useful in the treatment of inflammatory disease
DE59209704D1 (de) 2-Aminomethyl-chromane als Wirkstoffe in Arzneimitteln zur Behandlung von Erkrankungen des Zentralnervensystems
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
Jalaluddin et al. Antimicrobial activity of Curcuma longa L. extract on periodontal pathogens
SE8804570D0 (sv) New ciclosporin crystal form process for its produktion pharmaceutical compositions containing it and its use
RU94045825A (ru) Применение материала, полученного из mycobacterium vaccae для производства терапевтического средства для лечения психических заболеваний, способ лечения психических заболеваний, продукт, содержащий антигенный и/или иммунорегуляторный материал, фармацевтическое средство
FR2404625A1 (fr) Nouveaux 4-aminocyclohexanols et composition pharmaceutique les contenant
ES8608532A1 (es) Procedimiento para la preparacion de gangliosidos y sus derivados administrables por nebulizacion
DE69426471D1 (de) Verwendung von Sulodexid und von Arzneimitteln, die dieses enthalten, zur Behandlung der diabetischen Nephropathie
Whiteside A controlled study of benzydamine oral rinse (‘Difflam’) in general practice
FR2399252A1 (fr) Vaccin de masse moleculaire elevee contre la meningite a meningocoques du groupe c et procede pour sa preparation
ATE121298T1 (de) Verfahren zur herstellung eines antikaries- impfstoffes aus streptococcus mutans und impfzusammensetzung gegen karies in form von nasentropfen.
FR2364912A1 (fr) Nouvelles 11-deoxy-11-oxaprostaglandines
FR2357514A1 (fr) Nouvelles substances odorantes a odeur de musc et procede pour leur preparation
FR2393801A1 (fr) Nouveaux 9-hydroxyhexahydrodibenzo(b,d)pyranes, leurs derives substitues en position 1, leur procede de preparation et medicament les contenant
PT1231908E (pt) Composicao farmaceutica compreendendo um composto dador de no e sua utilizacao em terapia
FR2444714A1 (fr) Procede servant a la degradation enzymatique partielle ou totale d'une substance faiblement moleculaire
EP0093497A3 (en) Anthelmintic treatment
FR2607392B1 (fr) Procede pour la preparation d'une souche mutante de bordetella bronchiseptica utile pour la preparation d'un vaccin vivant attenue pour la prophylaxie des infections a b. bronchiseptica et vaccin vivant attenue contre la rhinite atrophique ainsi prepare
Wanka Alcohol-induced pain associated with adenocarcinoma of the bronchus

Legal Events

Date Code Title Description
TP Transmission of property